|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (1997)) |
IUPAC Name ![]() |
| 2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 7229 | irbesartan |
Synonyms ![]() |
| Aprovel® |
| Avapro® |
| SR 47436 |
Database Links ![]() |
|
| BindingDB Ligand | 50042235 |
| CAS Registry No. | 138402-11-6 |
| ChEBI | CHEBI:5959 |
| ChEMBL Ligand | CHEMBL1513 |
| DrugBank Ligand | DB01029 |
| PharmGKB Drug | PA450084 |
| PubChem CID | 3749 |
| Search Google for chemical match using the InChIKey | YOSHYTLCDANDAN-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | YOSHYTLCDANDAN |
| Search PubMed clinical trials | irbesartan |
| Search PubMed titles | irbesartan |
| Search PubMed titles/abstracts | irbesartan |
| Wikipedia | Irbesartan |
| Comments |
| Irbesartan is an angiotensin receptor antagonist. |